Found 103 matching trials
CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer(Cinnamon) PHASE3 This study is a Phase III non-inferiority trial targeting a specific subset...
Show More Location
Multiple Locations
Learn More & Join Trial
SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction PHASE3 To compare efficacy and safety between SGI-110 and Treatment Choice in adul...
Show More Location
Mayo Clinic Cancer Center
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) PHASE2 This study aims to evaluate the efficacy and safety of induction Adebrelima...
Show More Location
The Fourth Hospital of Hebei Medical University
Learn More & Join Trial
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer PHASE3 This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer PHASE4 The purpose of this study is to compare the safety and efficacy of epirubic...
Show More Learn More & Join Trial
Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer NA RATIONALE: Triple-negative breast cancer (TNBC) is an aggressive subtype sh...
Show More Location
Multiple Locations
Learn More & Join Trial
Tc99m Sestamibi Molecular Breast Imaging NA This clinical trial studies technetium Tc-99m sestamibi molecular breast im...
Show More Status
Active Not Recruiting
Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor PHASE3 This is a prospective, randomized, open-label, multicenter phase III study ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy PHASE2 This is a randomized open label dose finding study to evaluate the efficacy...
Show More Location
Community Hospital of Anderson
Learn More & Join Trial